Comparing PIEB and CEI for Labor Pain Relief

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorDa Nang Family General Hospital

About this trial

The purpose of this randomized controlled trial is to compare the efficacy and safety of two epidural analgesia maintenance methods for labor pain relief: Programmed Intermittent Epidural Bolus (PIEB) and Continuous Epidural Infusion (CEI), both combined with Patient-Controlled Epidural Analgesia (PCEA). The study aims to evaluate which technique provides superior analgesia while minimizing anesthetic consumption and preserving maternal motor function. A total of 60 parturients at Family Hospital, Da Nang, will be randomly assigned to either the PIEB or CEI group. Outcomes including pain intensity (VAS scores), total drug consumption, maternal satisfaction, and neonatal Apgar scores will be assessed.

Eligibility criteria

Qualifiers

Parturients indicated for labor analgesia for vaginal delivery via epidural anesthesia.

Age from 18 to 40 years.

Physical status: ASA II.

Singleton pregnancy, full-term, vertex presentation in labor.

Disqualifiers

Contraindications to epidural analgesia.

History of allergy to local anesthetics (Ropivacaine) or opioids (Fentanyl).

High-risk pregnancies: Preeclampsia, placenta previa, placental abruption.

Fetal distress or fetal abnormalities.

Trial design

Treatments tested in this trial

  • PIEB + PCEA
  • CEI + PCEA

Treatment groups

60 Participants
are divided into 2 treatment groups